{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:18:30Z","timestamp":1787019510821,"version":"build-2736575974"},"reference-count":62,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Allogeneic stem cell transplantation is an accepted treatment modality for selected malignant and non-malignant diseases. However, the ability to identify suitably matched related or unrelated donors can be difficult in some patients. Alternative sources of stem cells such as cord blood provide a readily available graft for such patients. Data accumulated over the past several years have demonstrated that the use of cord blood is an accepted source of stem cells for pediatric patients. Since the cell numbers of hematopoietic progenitors in cord blood is limited and the collection can occur only in a single occasion, its use in adult patients can be more problematic. Here, new developments in the use of cord blood for adults and studies aimed at expansion of cord blood cells and immune reconstitution are described.<\/jats:p>\n                  <jats:p>In Section I, Dr. Nelson Chao describes the early data in cord blood transplantation in adult patients. The patient outcomes are reviewed and analyzed for various factors such as cell dose, HLA typing, and patient selection that could have contributed to the final outcome of these adult patients. Myeloablative as well as nonmyeloablative approaches are presented. Discussion of the various benefits and risks are presented. More recent data from multiple single institutions as well as larger registry data comparisons are also provided. Analyses of these studies suggest methods to improve on the outcome. These newer data should lead to a logical progression in the use of cord blood cells in adult patients.<\/jats:p>\n                  <jats:p>In Section II, Dr. Stephen Emerson describes the historical efforts associated with expansion of hematopoietic stem cells, specifically with cord blood cells. These efforts to expand cord blood cells continue with novel methods. Moreover, a better understanding of stem cell biology and signaling is critical if we are to be able to effectively expand these cells for clinical use. An alternative, more direct, approach to expanding stem cells could be achieved by specific genetic pathways known or believed to support primitive HSC proliferation such as Notch-1 receptor activation, Wnt\/LEF-1 pathway induction, telomerase or the Homeobox (Hox) gene products. The clinical experience with the use of expanded cord blood cells is also discussed.<\/jats:p>\n                  <jats:p>In Section III, Dr. Kenneth Weinberg describes immune reconstitution or lack thereof following cord blood transplantation. One of the hallmarks of successful hematopoietic stem cell transplantation is the ability to fully reconstitute the immune system of the recipient. Thus, the relationship between stem cell source and the development of T lymphocyte functions required for protection of the recipient from infection will be described, and cord blood recipients will be compared with those receiving other sources of stem cells. T cell development is described in detail, tracking from prethymic to postthymic lymphocytes with specific attention to umbilical cord blood as the source of stem cells. Moreover, a discussion of the placenta as a special microenvironment for umbilical cord blood is presented. Strategies to overcome the immunological defects are presented to improve the outcome of these recipients.<\/jats:p>","DOI":"10.1182\/asheducation-2004.1.354","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T21:03:01Z","timestamp":1100898181000},"page":"354-371","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":55,"title":["Stem Cell Transplantation (Cord Blood Transplants)"],"prefix":"10.1182","volume":"2004","author":[{"given":"Nelson J.","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth I.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021215275553200_R1","unstructured":"Ende M, Ende N. Hematopoietic transplantation by means of fetal (cord) blood. Virginia Med Monthly. 1972;99:276\u2013280."},{"key":"2020021215275553200_R2","doi-asserted-by":"crossref","unstructured":"Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi\u2019s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174\u20131178.","DOI":"10.1056\/NEJM198910263211707"},{"key":"2020021215275553200_R3","doi-asserted-by":"crossref","unstructured":"Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med. 1993;328:593\u2013602.","DOI":"10.1056\/NEJM199303043280901"},{"key":"2020021215275553200_R4","doi-asserted-by":"crossref","unstructured":"Barker JN, Krepski TP, DeFor TE, et al. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant. 2002;8:257\u2013260.","DOI":"10.1053\/bbmt.2002.v8.pm12064362"},{"key":"2020021215275553200_R5","doi-asserted-by":"crossref","unstructured":"Gluckman E, Rocha V, Chevret S. Results of unrelated umbilical cord blood transplant. Transfus Clin Biol. 2001;8:146\u2013154.","DOI":"10.1016\/S1246-7820(01)00132-X"},{"key":"2020021215275553200_R6","doi-asserted-by":"crossref","unstructured":"Rocha V, Wagner JE Jr, Sobocinkski KA, et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000;342:1846\u20131854.","DOI":"10.1056\/NEJM200006223422501"},{"key":"2020021215275553200_R7","doi-asserted-by":"crossref","unstructured":"Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815\u20131822.","DOI":"10.1056\/NEJM200106143442402"},{"key":"2020021215275553200_R8","doi-asserted-by":"crossref","unstructured":"Sanz GF, Saavedra S, Planelles D, et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood. 2001;98:2332\u20132338.","DOI":"10.1182\/blood.V98.8.2332"},{"key":"2020021215275553200_R9","unstructured":"Rocha V, Arcese W, Sanz G, et al. Prognostic factors of outcome after unrelated cord blood transplant (UCBT) in adults with haematologic malignancies [abstract]. Blood. 2000;96:587a."},{"key":"2020021215275553200_R10","unstructured":"Goldberg SL, Chedid S, Jennis AA, Preti RA. Unrelated cord blood transplantation in adults: a single institution experience [abstract]. Blood. 2000;96:208a."},{"key":"2020021215275553200_R11","unstructured":"Cornetta K, Laughlin M, Carter S, et al. Umbilical cord blood transplantation in adults: results of a prospective, multi-institutional, NHBLI sponsored trial [abstract]. Blood. 2002;100:42a."},{"key":"2020021215275553200_R12","doi-asserted-by":"crossref","unstructured":"Ooi J, Iseki T, Takahashi A, et al. Unrelated cord blood transplantation for adults patients with de novo acute myeloid leukemia. Blood. 2004:103:489\u2013491.","DOI":"10.1182\/blood-2003-07-2420"},{"key":"2020021215275553200_R13","doi-asserted-by":"crossref","unstructured":"Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood. 2003;101:4711\u20134713.","DOI":"10.1182\/blood-2002-12-3917"},{"key":"2020021215275553200_R14","doi-asserted-by":"crossref","unstructured":"Long GD, Laughlin M, Madan B, et al. Unrelated cord blood transplantation in adult patients. Biol Blood Marrow Transplant. 2003:9:772\u201380.","DOI":"10.1016\/j.bbmt.2003.08.007"},{"key":"2020021215275553200_R15","unstructured":"Rubinstein P, Carrier C, Carpenter C, et al. Graft selection in unrelated placental\/umbilical cord blood (PCB) transplantation: influence and weight of HLA match and cell dose on engraftment and survival [abstract]. Blood. 2000;96:588a."},{"key":"2020021215275553200_R16","doi-asserted-by":"crossref","unstructured":"Rizzieri DA, Long GD, Vredenburgh JJ et al. Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. Blood. 2001;98:3486\u20133488.","DOI":"10.1182\/blood.V98.12.3486"},{"key":"2020021215275553200_R17","doi-asserted-by":"crossref","unstructured":"Chao NJ, Koh L-P, Long GD, et al. Adult recipients of umbilical cord blood transplantation following non-myeloablative preparative regimen. Biol Blood Marrow Transplant.2004. In press.","DOI":"10.1016\/j.bbmt.2004.05.001"},{"key":"2020021215275553200_R18","doi-asserted-by":"crossref","unstructured":"Barker JN, Weisdorf DJ, DeFor TE, et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced intensity conditioning. Blood. 2003;102:1915\u20131919.","DOI":"10.1182\/blood-2002-11-3337"},{"key":"2020021215275553200_R19","unstructured":"McSweeney PA, Bearman SI, Jones RB, et al. Nonmyeloablative hematopoietic cell transplant using cord blood [abstract]. Blood2001;98:666a."},{"key":"2020021215275553200_R20","doi-asserted-by":"crossref","unstructured":"Chao NJ, Liu CX, Rooney B, et al. Nonmyeloablative regimen preserves \u2018niches\u2019 allowing for peripheral expansion of donor T cells. Biol Blood Marrow Transplant. 2002;8:249\u2013256.","DOI":"10.1053\/bbmt.2002.v8.pm12064361"},{"key":"2020021215275553200_R21","unstructured":"Rocha V, Labopin M, Frasoni F, et al. Results of unrelated cord blood versus unrelated bone marrow transplant in adults with acute leukemia. Blood. 2002;100:148."},{"key":"2020021215275553200_R22","unstructured":"Laughlin M, Rubinstein P, Stevens C, et al. Comparison of unrelated cord blood and unrelated bone marrow transplants for leukemia in adults: a collaborative study of the International Bone Marrow Transplant Registry and the New York Blood Center. Blood. 2003;103:857."},{"key":"2020021215275553200_R23","doi-asserted-by":"crossref","unstructured":"Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem\/progenitor cells. Proc Nat Acad Sci U S A. 1989;86:3828\u20133832.","DOI":"10.1073\/pnas.86.10.3828"},{"key":"2020021215275553200_R24","doi-asserted-by":"crossref","unstructured":"Carow CE, Hangoc G, Cooper SH, Williams DE, Broxmeyer HE. Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential. Blood. 1991;78:2216\u20132221.","DOI":"10.1182\/blood.V78.9.2216.2216"},{"key":"2020021215275553200_R25","doi-asserted-by":"crossref","unstructured":"Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood and adult marrow. Exp Hem. 1999;27:1418\u20131427.","DOI":"10.1016\/S0301-472X(99)00078-8"},{"key":"2020021215275553200_R26","doi-asserted-by":"crossref","unstructured":"Rocha, V, Wagner JE, Sobocinski K, et al. Comparison of graft-vs-host disease in children transplanted with HLA identical sibling umbilical cord blood vs HLA identical sibling bone marrow transplant. N Engl J Med. 2000;342:1847\u20131854.","DOI":"10.1056\/NEJM200006223422501"},{"key":"2020021215275553200_R27","doi-asserted-by":"crossref","unstructured":"Uchida N, Aguila HL, Fleming WH, Jerabek L, Weissman IL. Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1lo Lin-Sca-1+ hematopoietic stem cells. Blood. 1994;83:3758\u20133779.","DOI":"10.1182\/blood.V83.12.3758.3758"},{"key":"2020021215275553200_R28","doi-asserted-by":"crossref","unstructured":"BitMansour A, Burns SM, Traver D, et al. Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood. 2002;100(13):4660\u20134667.","DOI":"10.1182\/blood-2002-05-1552"},{"key":"2020021215275553200_R29","doi-asserted-by":"crossref","unstructured":"Dorrell C, Gan OI, Pereira DS, Hawley RG, Dick JE. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood. 2000;95:102\u2013110.","DOI":"10.1182\/blood.V95.1.102"},{"key":"2020021215275553200_R30","doi-asserted-by":"crossref","unstructured":"Larochelle A. Vormoor J. Hanenberg H. et al. Identification of primitive human hematopoietic cells capable of repopulating NOD\/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996;2:1329\u20131337.","DOI":"10.1038\/nm1296-1329"},{"key":"2020021215275553200_R31","unstructured":"Moore MA. Hoskins I. Ex vivo expansion of cord blood-derived stem cells and progenitors. Blood Cells. 1994;20:468\u2013479."},{"key":"2020021215275553200_R32","unstructured":"Van Zant G, Drubachevsky I, Rummel S, Koller MF, Emerson SG. Expansion of hematopoietic progenitor cells from umbilical cord blood via continuous perfusion culture. Blood Cells. 1994;20:482\u2013491."},{"key":"2020021215275553200_R33","doi-asserted-by":"crossref","unstructured":"Lewis ID, Du J, Almeida-Porada J, Zanjani ED, Verfaillie CM. Long-term repopulating cord blood stem cells are preserved after ex-vivo culture in a non-contact system. Blood. 2001:3441\u20133449.","DOI":"10.1182\/blood.V97.11.3441"},{"key":"2020021215275553200_R34","doi-asserted-by":"crossref","unstructured":"Glimm H, Tang P, Clark-Lewis I, von Kalle C, Eaves C. Ex vivo treatment of proliferating human cord blood stem cells with stroma-derived factor-1 enhances their ability to engraft NOD\/SCID mice. Blood. 2002;99:3454\u20133457.","DOI":"10.1182\/blood.V99.9.3454"},{"key":"2020021215275553200_R35","doi-asserted-by":"crossref","unstructured":"Zandstra PW, Conneally E, Piret JM, Eaves CJ. Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells. Br J Haematol. 1998;101:770\u2013778.","DOI":"10.1046\/j.1365-2141.1998.00777.x"},{"key":"2020021215275553200_R36","doi-asserted-by":"crossref","unstructured":"Antonchuk J, Sauvageau G, Humphries RK. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell. 2002;109:39\u201345.","DOI":"10.1016\/S0092-8674(02)00697-9"},{"key":"2020021215275553200_R37","doi-asserted-by":"crossref","unstructured":"Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med. 2003;9:1428\u20131432.","DOI":"10.1038\/nm951"},{"key":"2020021215275553200_R38","doi-asserted-by":"crossref","unstructured":"Zhu J, Gianolla D, Zhang Y, Rivera A, Emerson SG. NF-Ya,b,c interacts with USF1\/2 to activate the HOXB4 promoter in human hematopoietic cells and repress granulopoiesis. Blood. 2003;102:2420\u20132427.","DOI":"10.1182\/blood-2003-01-0251"},{"key":"2020021215275553200_R39","doi-asserted-by":"crossref","unstructured":"Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 2002;8:368\u2013376.","DOI":"10.1053\/bbmt.2002.v8.pm12171483"},{"key":"2020021215275553200_R40","doi-asserted-by":"crossref","unstructured":"Pecora A, Stiff P, Jennis A, et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant. 2000;25:797\u2013799.","DOI":"10.1038\/sj.bmt.1702222"},{"key":"2020021215275553200_R41","doi-asserted-by":"crossref","unstructured":"Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 2003;101:5061\u20135067.","DOI":"10.1182\/blood-2001-12-0290"},{"key":"2020021215275553200_R42","doi-asserted-by":"crossref","unstructured":"Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003;102:1915\u20131919.","DOI":"10.1182\/blood-2002-11-3337"},{"key":"2020021215275553200_R43","doi-asserted-by":"crossref","unstructured":"Ochs L, Shu XO, Miller J, et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood. 1995;86:13979\u201313986.","DOI":"10.1182\/blood.V86.10.3979.bloodjournal86103979"},{"key":"2020021215275553200_R44","doi-asserted-by":"crossref","unstructured":"Mackall CL, Gress RE. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev. 1997;157:61\u201372.","DOI":"10.1111\/j.1600-065X.1997.tb00974.x"},{"key":"2020021215275553200_R45","doi-asserted-by":"crossref","unstructured":"Weinberg K, Blazar BR, Wagner JE, et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97:1458\u20131466.","DOI":"10.1182\/blood.V97.5.1458"},{"key":"2020021215275553200_R46","doi-asserted-by":"crossref","unstructured":"Storek J, Joseph A, Dawson MA, Douek DC, Storer B, Maloney DG. Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation. Transplantation. 2002;73:1154\u20131158.","DOI":"10.1097\/00007890-200204150-00026"},{"key":"2020021215275553200_R47","doi-asserted-by":"crossref","unstructured":"Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nature Immunol. 2000;1:426\u2013432.","DOI":"10.1038\/80868"},{"key":"2020021215275553200_R48","doi-asserted-by":"crossref","unstructured":"Chen BJ, Cui X, Sempowski GD, Domen J, Chao NJ. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood. 2004;103:4344\u20134352.","DOI":"10.1182\/blood-2003-07-2534"},{"key":"2020021215275553200_R49","doi-asserted-by":"crossref","unstructured":"Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM. A functional comparison of CD34+ CD38\u2212 cells in cord blood and bone marrow. Blood. 1995;86:3745\u20133753.","DOI":"10.1182\/blood.V86.10.3745.bloodjournal86103745"},{"key":"2020021215275553200_R50","doi-asserted-by":"crossref","unstructured":"McCracken S, Layton JE, Shorter SC, Starkey PM, Barlow DH, Mardon HJ. Expression of granulocyte-colony stimulating factor and its receptor is regulated during the development of the human placenta. J Endocrinol. 1996;149:249\u2013258.","DOI":"10.1677\/joe.0.1490249"},{"key":"2020021215275553200_R51","doi-asserted-by":"crossref","unstructured":"Arber C, BitMansour A, Sparer TE, et al. Common lymphoid progenitors rapidly engraft and protect against cytomegalovirus infection after hematopoietic stem cell transplantation. Blood. 2003;102:421\u2013428.","DOI":"10.1182\/blood-2002-12-3834"},{"key":"2020021215275553200_R52","doi-asserted-by":"crossref","unstructured":"Lewis DB, Yu CC, Meyer J, English BK, Kahn SJ, Wilson CB. Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J Clin Invest. 1991;87:194\u2013202.","DOI":"10.1172\/JCI114970"},{"key":"2020021215275553200_R53","doi-asserted-by":"crossref","unstructured":"Fagnoni FF, Oliviero B, Giorgiani G, et al. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. Blood. 2004;104:281\u2013289.","DOI":"10.1182\/blood-2003-07-2443"},{"key":"2020021215275553200_R54","doi-asserted-by":"crossref","unstructured":"Klein AK, Patel DD, Gooding ME, et al. T-cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2001;7:454\u2013466.","DOI":"10.1016\/S1083-8791(01)80013-6"},{"key":"2020021215275553200_R55","doi-asserted-by":"crossref","unstructured":"Talvensaari K, Clave E, Douay C, et al. A broad T-cell repertoire and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood. 2002;99:1458\u20131464.","DOI":"10.1182\/blood.V99.4.1458"},{"key":"2020021215275553200_R56","doi-asserted-by":"crossref","unstructured":"Hamza NS, Lisgaris M, Yadavalli G, et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol. 2004;124:488\u2013498.","DOI":"10.1046\/j.1365-2141.2003.04792.x"},{"key":"2020021215275553200_R57","doi-asserted-by":"crossref","unstructured":"Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565\u20131577.","DOI":"10.1056\/NEJM199811263392201"},{"key":"2020021215275553200_R58","doi-asserted-by":"crossref","unstructured":"Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 2001;97:2962\u20132971.","DOI":"10.1182\/blood.V97.10.2962"},{"key":"2020021215275553200_R59","doi-asserted-by":"crossref","unstructured":"Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611\u20131618.","DOI":"10.1182\/blood-2002-01-0294"},{"key":"2020021215275553200_R60","doi-asserted-by":"crossref","unstructured":"Tomonari A, Iseki T, Ooi J, et al. Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan. Br J Haematol. 2003;121:304\u2013311.","DOI":"10.1046\/j.1365-2141.2003.04264.x"},{"key":"2020021215275553200_R61","doi-asserted-by":"crossref","unstructured":"Sashihara J, Tanaka-Taya K, Tanaka S, et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood. 2002;100:2005\u20132011.","DOI":"10.1182\/blood.V100.6.2005"},{"key":"2020021215275553200_R62","doi-asserted-by":"crossref","unstructured":"Allman D, Karnell FG, Punt JA, et al. Separation of Notch1 promoted lineage commitment and expansion\/transformation in developing T cells. J Exp Med. 2001;194:99\u2013106.","DOI":"10.1084\/jem.194.1.99"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2004\/1\/354\/1634468\/354_371ash.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2004\/1\/354\/1634468\/354_371ash.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T01:29:32Z","timestamp":1624930172000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2004\/1\/354\/18684\/Stem-Cell-Transplantation-Cord-Blood-Transplants"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2004.1.354","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,1]]}}}